Delving into the Latest Updates on Nanjing Yifang Pharmacy Research&Development Center Co.,Ltd. with Synapse

Overview

主要目的：研究浙江海正药业股份有限公司研制生产的注射用白蛋白紫杉醇和参比制剂注射用紫杉醇(白蛋白结合型)（Abraxane)的人体生物等效性。次要目的：评价浙江海正药业股份有限公司生产的注射用白蛋白紫杉醇的安全性和有效性。

[Translation]

Primary objective: To study the bioequivalence of nab-paclitaxel for injection developed and produced by Zhejiang Hisun Pharmaceutical Co., Ltd. and the reference preparation paclitaxel for injection (albumin-bound) (Abraxane) in humans. Secondary objective: To evaluate the safety and efficacy of nab-paclitaxel for injection produced by Zhejiang Hisun Pharmaceutical Co., Ltd.

Start Date12 Dec 2016

Sponsor / Collaborator

Zhejiang Hisun Pharmaceutical Co., Ltd.

[+2]

100 Clinical Results associated with Nanjing Yifang Pharmacy Research&Development Center Co.,Ltd.

Login to view more data

0 Patents (Medical) associated with Nanjing Yifang Pharmacy Research&Development Center Co.,Ltd.

Login to view more data

100 Deals associated with Nanjing Yifang Pharmacy Research&Development Center Co.,Ltd.

Login to view more data

100 Translational Medicine associated with Nanjing Yifang Pharmacy Research&Development Center Co.,Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

2

Login to view more data